Construction of a miR-15a-based risk prediction model for vascular calcification detection in patients undergoing hemodialysis

References

• Polkinghorne KR. ESKD or cancer: given the choice, which would you rather have? Am J Kidney Dis. 2019;73(6):1–10. doi: 10.1053/j.ajkd.2019.01.037.
   PubMed Web of Science ®Google Scholar
• Hundemer GL, Sood MM. Predialysis care and cardiovascular outcomes: why the lead up to dialysis matters. Kidney Int Rep. 2019;4(5):635–637. doi: 10.1016/j.ekir.2019.03.010.
   PubMed Web of Science ®Google Scholar
• Chen SC, Teh M, Huang JC, et al. Increased aortic arch calcification and cardiomegaly is associated with rapid renal progression and increased cardiovascular mortality in chronic kidney disease. Sci Rep. 2019;9(1):5354. doi: 10.1038/s41598-019-41841-7.
   PubMedGoogle Scholar
• Zhang H, Li G, Yu X, et al. Progression of vascular calcification and clinical outcomes in patients receiving maintenance dialysis. JAMA Netw Open. 2023;6(5):e2310909. doi: 10.1001/jamanetworkopen.2023.10909.
   PubMed Web of Science ®Google Scholar
• Sørensen I, Saurbrey S, Hjortkjær HØ, et al. Regional distribution and severity of arterial calcification in patients with chronic kidney disease stages 1-5: a cross-sectional study of the Copenhagen chronic kidney disease cohort. BMC Nephrol. 2020;21(1):534. doi: 10.1186/s12882-020-02192-y.
   PubMed Web of Science ®Google Scholar
• Kraus MA, Kalra PA, Hunter J, et al. The prevalence of vascular calcification in patients with end-stage renal disease on hemodialysis: a cross-sectional observational study. Ther Adv Chronic Dis. 2015;6(3):84–96. doi: 10.1177/2040622315578654.
   PubMed Web of Science ®Google Scholar
• Choi SR, Lee Y, Cho AJ, et al. Malnutrition, inflammation, progression of vascular calcification and survival: inter-relationships in hemodialysis patients. PLoS One. 2019;14(5):e0216415. doi: 10.1371/journal.pone.0216415.
   PubMed Web of Science ®Google Scholar
• Kakani E, Elyamny M, Ayach T, et al. Pathogenesis and management of vascular calcification in CKD and dialysis patients. Semin Dial. 2019;32(6):553–561. doi: 10.1111/sdi.12840.
   PubMed Web of Science ®Google Scholar
• Goodman WG, Goldin J, Kuizon BD, et al. Coronary-Artery calcification in young adults with end-stage renal disease who are undergoing dialysis. N Engl J Med. 2000;342(20):1478–1483. doi: 10.1056/NEJM200005183422003.
   PubMed Web of Science ®Google Scholar
• Dilsizian V, Gewirtz H, Marwick TH, et al. Cardiac imaging for coronary heart disease risk stratification in chronic kidney disease. JACC Cardiovasc Imaging. 2021;14(3):669–682. doi: 10.1016/j.jcmg.2020.05.035.
   PubMed Web of Science ®Google Scholar
• Hsu JJ, Tintut Y, Demer LL. A biomarker for vascular calcification: shedding light on an unfinished story? Cardiovasc Res. 2021;117(8):1809–1810. doi: 10.1093/cvr/cvab071.
   PubMed Web of Science ®Google Scholar
• Saliminejad K, Khorram Khorshid HR, Soleymani Fard S, et al. An overview of microRNAs: biology, functions, therapeutics, and analysis methods. J Cell Physiol. 2019;234(5):5451–5465. doi: 10.1002/jcp.27486.
   PubMed Web of Science ®Google Scholar
• Jafarzadeh Esfehani R, Mostafa Parizadeh S, Sabeti Aghabozorgi A, et al. Circulating and tissue microRNAs as a potential diagnostic biomarker in patients with thrombotic events. J Cell Physiol. 2020;235(10):6393–6403. doi: 10.1002/jcp.29639.
   PubMed Web of Science ®Google Scholar
• Liu Z, Yang D, Gao J, et al. Discovery and validation of miR-452 as an effective biomarker for acute kidney injury in sepsis. Theranostics. 2020;10(26):11963–11975. doi: 10.7150/thno.50093.
   PubMed Web of Science ®Google Scholar
• Meuth VM, Metzinger L. miR-223 and other miRNA’s evaluation in chronic kidney disease: innovative biomarkers and therapeutic tools. Noncoding RNA Res. 2019;4(1):30–35. doi: 10.1016/j.ncrna.2019.01.002.
   PubMed Web of Science ®Google Scholar
• Gao W, Jin L, Li D, et al. The association between the body roundness index and the risk of colorectal cancer: a cross-sectional study. Lipids Health Dis. 2023;22(1):59. doi: 10.1186/s12944-023-01814-2.
   PubMed Web of Science ®Google Scholar
• Aomatsu A, Kaneko S, Yanai K, et al. MicroRNA expression profiling in acute kidney injury. Transl Res. 2022;244:1–31. doi: 10.1016/j.trsl.2021.11.010.
   PubMed Web of Science ®Google Scholar
• Yao X, Zhai Y, An H, et al. MicroRNAs in IgA nephropathy. Ren Fail. 2021;43(1):1298–1310. doi: 10.1080/0886022X.2021.1977320.
   PubMed Web of Science ®Google Scholar
• Voelkl J, Cejka D, Alesutan I. An overview of the mechanisms in vascular calcification during chronic kidney disease. Curr Opin Nephrol Hypertens. 2019;28(4):289–296. doi: 10.1097/MNH.0000000000000507.
   PubMed Web of Science ®Google Scholar
• Kaur R, Singh R. Mechanistic insights into CKD-MBD-related vascular calcification and its clinical implications. Life Sci. 2022;311:121148. doi: 10.1016/j.lfs.2022.121148.
   Google Scholar
• Jiang L, Yin Q, Yang M, et al. Fibroblast growth factor 21 predicts and promotes vascular calcification in haemodialysis patients. Kidney Dis (Basel). 2021;7(3):227–240. doi: 10.1159/000512750.
   PubMed Web of Science ®Google Scholar
• Clemente A, Traghella I, Mazzone A, et al. Vascular and valvular calcification biomarkers. Adv Clin Chem. 2020;95:73–103. doi: 10.1016/bs.acc.2019.08.002.
   PubMed Web of Science ®Google Scholar
• Koide T, Mandai S, Kitaoka R, et al. Circulating extracellular vesicle-propagated microRNA signature as a vascular calcification factor in chronic kidney disease. Circ Res. 2023;132(4):415–431. doi: 10.1161/CIRCRESAHA.122.321939.
   PubMed Web of Science ®Google Scholar
• Liao X, Zhang Z, Yuan K, et al. MiR-133a modulates osteogenic differentiation of vascular smooth muscle cells. Endocrinology. 2013;154(9):3344–3352. doi: 10.1210/en.2012-2236.
   PubMed Web of Science ®Google Scholar
• Guo Y, Bao S, Guo W, et al. Bone marrow mesenchymal stem cell-derived exosomes alleviate high phosphorus-induced vascular smooth muscle cells calcification by modifying microRNA profiles. Funct Integr Genomics. 2019;19(4):633–643. doi: 10.1007/s10142-019-00669-0.
   PubMed Web of Science ®Google Scholar
• Luo F, Guo W, Liu W. Exosomes derived from bone marrow mesenchymal stem cells inhibit human aortic vascular smooth muscle cells calcification via the miR-15a/15b/16/NFATc3/OCN axis. Biochem Biophys Res Commun. 2022;635:65–76. doi: 10.1016/j.bbrc.2022.09.076.
   PubMed Web of Science ®Google Scholar
• Wu J, Zhang H, Li L, et al. A nomogram for predicting overall survival in patients with low-grade endometrial stromal sarcoma: a population-based analysis. Cancer Commun (Lond). 2020;40(7):301–312. doi: 10.1002/cac2.12067.
   PubMed Web of Science ®Google Scholar
• Silva RE, Simões-E-Silva AC, Miranda AS, et al. Potential role of nutrient intake and malnutrition as predictors of uremic oxidative toxicity in patients with end-stage renal disease. Oxid Med Cell Longev. 2019;2019:7463412–7463412. doi: 10.1155/2019/7463412.
   PubMed Web of Science ®Google Scholar
• Kauppila LI, Polak JF, Cupples LA, et al. New indices to classify location, severity and progression of calcific lesions in the abdominal aorta: a 25-year follow-up study. Atherosclerosis. 1997;132(2):245–250. doi: 10.1016/s0021-9150(97)00106-8.
   PubMed Web of Science ®Google Scholar
• Dube P, DeRiso A, Patel M, et al. Vascular calcification in chronic kidney disease: diversity in the vessel wall. Biomedicines. 2021;9(4):404. doi: 10.3390/biomedicines9040404.
   PubMed Web of Science ®Google Scholar
• Lioufas NM, Pedagogos E, Hawley CM, et al. Aortic calcification and arterial stiffness burden in a chronic kidney disease cohort with high cardiovascular risk: baseline characteristics of the impact of phosphate reduction on vascular End-Points in chronic kidney disease trial. Am J Nephrol. 2020;51(3):201–215. doi: 10.1159/000505717.
   PubMed Web of Science ®Google Scholar
• Mohamed BA, Yang W, Litt H, et al. Valvular calcification, inflammation, and mortality in dialysis patients. J. Heart Valve Dis. 2013;22(4):584–590.
   Google Scholar
• Xiong L, Chen Q, Cheng Y, et al. The relationship between coronary artery calcification and bone metabolic markers in maintenance hemodialysis patients. BMC Nephrol. 2023;24(1):238. 238. doi: 10.1186/s12882-023-03286-z.
   PubMed Web of Science ®Google Scholar
• Adragao T, Ferreira A, Frazao JM, et al. Higher mineralized bone volume is associated with a lower plain X-ray vascular calcification score in hemodialysis patients. PLoS One. 2017;2(7):e0179868. doi: 10.1371/journal.pone.0179868.
   Google Scholar
• Moe SM, Chertow GM, Parfrey PS, et al. Cinacalcet, fibroblast growth factor-23, and cardiovascular disease in hemodialysis: the evaluation of cinacalcet HCl therapy to lower cardiovascular events (EVOLVE) trial. Circulation. 2015;132(1):27–39. doi: 10.1161/CIRCULATIONAHA.114.013876.
   PubMed Web of Science ®Google Scholar
• Li J, Li M, Gao F, et al. Serum microRNA-15a level acts as a potential diagnostic and prognostic biomarker for human esophageal squamous cell carcinoma. Cancer Biomark. 2017;18(1):11–17. doi: 10.3233/CBM-160667.
   PubMed Web of Science ®Google Scholar
• Zheng M, Wang M. A narrative review of the roles of the miR-15/107 family in heart disease: lessons and prospects for heart disease. Ann Transl Med. 2021;9(1):66–66. doi: 10.21037/atm-20-6073.
   PubMed Web of Science ®Google Scholar
• Chava S, Reynolds CP, Pathania AS, et al. miR-15a-5p, miR-15b-5p, and miR-16-5p inhibit tumor progression by directly targeting MYCN in neuroblastoma. Mol Oncol. 2020;14(1):180–196. doi: 10.1002/1878-0261.12588.
   PubMed Web of Science ®Google Scholar
• Panizo S, Naves-Diaz M, Carrillo-Lopez N, et al. MicroRNAs 29b, 133b, and 211 regulate vascular smooth muscle calcification mediated by high phosphorus. J Am Soc Nephrol. 2016;27(3):824–834. doi: 10.1681/ASN.2014050520.
   PubMed Web of Science ®Google Scholar
• Liu X, Wu P, Zhang H, et al. MicroRNA-211-5p as a biomarker in early detection of uremic vascular calcification among patients with end-stage renal disease. Arch Esp Urol. 2022;75(8):714–719. doi: 10.56434/j.arch.esp.urol.20227508.103.
   PubMed Web of Science ®Google Scholar
• Chao CT, Yeh HY, Tsai YT, et al. A combined microRNA and target protein-based panel for predicting the probability and severity of uraemic vascular calcification: a translational study. Cardiovasc Res. 2021;117(8):1958–1973. doi: 10.1093/cvr/cvaa255.
   PubMed Web of Science ®Google Scholar
• Chao C, Liu Y, Su S, et al. Circulating MicroRNA-125b predicts the presence and progression of uremic vascular calcification. Arterioscler Thromb Vasc Biol. 2017;37(7):1402–1414. doi: 10.1161/ATVBAHA.117.309566.
   PubMed Web of Science ®Google Scholar
• Hou L, Lloyd-Jones DM, Ning H, et al. White blood cell count in young adulthood and coronary artery calcification in early Middle age: coronary artery risk development in young adults (CARDIA) study. Journal of epidemiology. Eur J Epidemiol. 2013;28(9):735–742. doi: 10.1007/s10654-013-9842-7.
   PubMed Web of Science ®Google Scholar
• Mozos I, Borzak G, Caraba A, et al. Arterial stiffness in hematologic malignancies. Onco Targets Ther. 2017;10:1381–1388. doi: 10.2147/OTT.S126852.
   PubMed Web of Science ®Google Scholar
• Mozos I, Malainer C, Horbańczuk J, et al. Inflammatory markers for arterial stiffness in cardiovascular diseases. Front Immunol. 2017;8:1058–1058. doi: 10.3389/fimmu.2017.01058.
   PubMed Web of Science ®Google Scholar
• Ayhan H, Kasapkara HA, Aslan AN, et al. Relationship of neutrophil-to-Lymphocyte ratio with aortic stiffness in type 1 diabetes mellitus. Can J Diabetes. 2015;39(4):317–321. doi: 10.1016/j.jcjd.2015.01.004.
   PubMed Web of Science ®Google Scholar
• Kukida M, Mogi M, Kan-No H, et al. AT2 receptor stimulation inhibits phosphate-induced vascular calcification. Kidney Int. 2019;95(1):138–148. doi: 10.1016/j.kint.2018.07.028.
   PubMed Web of Science ®Google Scholar